Categories: Healthcare

Global Allergy Conjunctivitis Market Size and Forecast 2024-2033|llergan PLC, AbbVie Inc., Ajanta Pharma Limited, Akron Operating Company LLC, Alcon Inc

A Young Bearded Man is Walking in Public Park and Dropping Liquid in his Eye with Eye-dropper. Vision and Ophthalmology Medicine Health Concept.

The Allergy Conjunctivitis Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Allergy Conjunctivitis Market:

https://www.thebusinessresearchcompany.com/report/allergy-conjunctivitis-global-market-report

According to The Business Research Company’s Allergy Conjunctivitis Global Market Report 2024, The allergy conjunctivitis market size has grown strongly in recent years. It will grow from $2.4 billion in 2023 to $2.54 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing incidence of allergic conditions, advancements in research and development, changing lifestyles and environmental factors, expansion of patient awareness, collaborations and partnerships, healthcare infrastructure development.

The allergy conjunctivitis market size is expected to see strong growth in the next few years. It will grow to $3.2 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing global allergy burden, personalized medicine approaches, growing geriatric population, biotechnological innovations, expanding healthcare access in developing regions, regulatory support and approvals.. Major trends in the forecast period include integration of novel drug delivery technologies, emphasis on patient education and awareness, development of combination therapies, incorporation of artificial intelligence (ai) in diagnosis, rise in environmental allergen management solutions.

The rise in exposure to air pollutants and chemicals is expected to boost the growth of the allergy conjunctivitis market going forward. Human eyes, one of the most sensitive parts of the human body, are constantly at risk due to ongoing exposure to the poisons in air pollution. Long-term exposure to airborne pollutants and chemicals causes a variety of eye issues, including allergic conjunctivitis, allergies, burning, watering, blurred vision, redness, itching, and persistent discomfort, requiring treatments. For instance, according to the United States Environmental Protection Agency (EPA), an independent executive agency of the United States federal government tasked with environmental protection matters, in the United States, around 67 million tons of pollutants were released into the atmosphere in 2021. Therefore, the rise in exposure to air pollutants and chemicals is driving the growth of the allergy conjunctivitis market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8806&type=smp

The allergy conjunctivitis market covered in this report is segmented –

1) By Drug Class: Antihistamines and Mast Cell Stabilizers, Corticosteroids, Other Drug Classes

2) By Disease Type: Mild, Severe

3) By Distribution Channel: Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies

Product innovation is the key trend gaining popularity in the allergy conjunctivitis market. Major companies operating in the allergy conjunctivitis market are focused on developing innovative and advanced products to strengthen their market position. For instance, in March 2022, Allergan, an Irish- US-based medical company launched LASTACAFT, an eye allergy drops. The LASTACAFT brand provides relief in as little as three minutes from itchiness and allergies and lasts through 16 hours. LASTACAFT is instilled directly in the eye to block the histamines that initiate ocular itching to quickly calm the allergic response and provide relief throughout the day from itchy eyes. This solution is an antihistamine eye drop that temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair, and dander for ages two and older. With this new solution, the company can provide quality eye care products and expands their retail eye drop portfolio.

The allergy conjunctivitis market report table of contents includes:

1. Executive Summary

2. Allergy Conjunctivitis Market Characteristics

3. Allergy Conjunctivitis Market Trends And Strategies

4. Allergy Conjunctivitis Market – Macro Economic Scenario

5. Global Allergy Conjunctivitis Market Size and Growth

26. South America Allergy Conjunctivitis Market

27. Brazil Allergy Conjunctivitis Market

28. Middle East Allergy Conjunctivitis Market

29. Africa Allergy Conjunctivitis Market

30. Allergy Conjunctivitis Market Competitive Landscape And Company Profiles

Top Major Players: